DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Meta-Analysis to Support UK Health Technology Assessment Submissions: A Review of NICE and Evidence Review Group Critiques

The quality of evidence used in manufacturers’ submissions for technology appraisal (TA) is an important factor in receiving a positive recommendation from health technology assessment (HTA) bodies. In the absence of evidence from head-to-head randomised controlled trials (RCTs), National Institute for Health and Care Excellence (NICE) guidelines recommend the use of indirect comparison (IC) and network meta-analysis (NMA). In the sixth edition of our DRG investigative series, we assess the use of ICs/NMAs in HTA submissions and identify common criticisms highlighted by NICE and Evidence Review Groups (ERGs).